November 18, 2025

ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!

  ANDA application for Bimatoprost ophthalmic solution, managed by CBCC received Marketing Authorization from the USFDA! Type of Study: Clinical endpoint Therapeutic Area: Ophthalmology Scope: End-to-end clinical trial management Countries of Trial Execution: USA & India CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas ClinicalResearch PharmaceuticalScience DrugDevelopment ClinicalTrials PhaseITrial MedicalResearch